Erratum: Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection (Oncogene (2005) 24 (1302-1308) DOI:10.1038/sj.onc.1208263);Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection

Oncogene

Volumn 24, Issue 7, 2005, Pages 1302-1308

  Suzuki, Makoto ^a,b   Toyooka, Shinichi ^a   Shivapurkar, Narayan ^a,c   Shigematsu, Hisayuki ^a   Miyajima, Kuniharu ^a   Takahashi, Takao ^a   Stastny, Victor ^a   Zern, Andrea L ^a   Fujisawa, Takehiko ^b   Pass, Harvey I ^d   Carbone, Michele ^e   Gazdar, Adi F ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

^e LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Malignant mesothelioma; Methylation; SV40

Indexed keywords

ARTICLE; CORRELATION FUNCTION; CRBP1 GENE; CYCLIN D2 GENE; DCR1 GENE; DNA METHYLATION; HIC 1 GENE; HPP1 GENE; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; RASSF1A GENE; RRAD GENE; SIMIAN VIRUS 40; SURVIVAL TIME; TMS1 GENE; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

EID: 20044363262     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.100     Document Type: Erratum

References (48)

1. Baas P. (2003). Curr. Opin. Oncol., 15, 127-130.
2. Bird AP. (1986). Nature, 321, 209-213.
3. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P and Carbone M. (2000). Proc. Natl. Acad. Sci. USA, 97, 10214-10219.
4. Cicala C, Pompetti F and Carbone M. (1993). Am. J. Pathol., 142, 1524-1533.
5. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST and Vertino PM. (2000). Cancer Res., 60, 6236-6242.
6. Du Y, Carling T, Fang W, Piao Z, Sheu JC and Huang S. (2001). Cancer Res., 61, 8094-8099.
7. Edwards JG, McLaren J, Jones JL, Waller DA and O'Byrne KJ. (2003). Br. J. Cancer, 88, 1553-1559.
8. Esteller M, Corn PG, Baylin SB and Herman JG. (2001). Cancer Res., 61, 3225-3229.
9. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB and Herman JG. (2002). Cancer Res., 62, 5902-5905.
10. Gazdar AF, Butel JS and Carbone M. (2002). Nat. Rev. Cancer, 2, 957-964.
11. Gazdar AF and Carbone M. (2003). Clin. Lung Cancer, 5, 177-181.
12. Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Richards WG, Jaklitsch MT, Sugarbaker DJ and Bueno R. (2003). J. Natl. Cancer Inst., 95, 598-605.
13. Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S and Tsuchiya E. (2001). Anticancer Res., 21, 535-540.
14. Hesson L, Dallol A, Minna JD, Maher ER and Latif F. (2003). Oncogene, 22, 947-954.
15. Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E and Kelsey KT. (2002). Carcinogenesis, 23, 1127-1130.
16. Hsu DR, Economides AN, Wang X, Eimon PM and Harland RM. (1998). Mol. Cell, 1, 673-683.
17. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG and Ro JY. (2002). Am. J. Pathol., 160, 787-794.
18. Nicoll G, Crichton DN, McDowell HE, Kernohan N, Hupp TR and Thompson AM. (2001). Br. J. Cancer, 85, 1878-1882.
19. Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD and Gazdar AF. (2003). Clin. Cancer Res., 9, 4730-4734.
20. Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW and Matthews WJ. (1995). Ann. Thorac. Surg., 59, 835-844.
21. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL. (1996). J. Cell Biochem. Suppl., 24, 32-91.
22. Powers A and Carbone M. (2002). Cancer Biol. Ther., 1, 348-353.
23. Rathi A, Virmani AK, Harada K, Timmons CF, Miyajima K, Hay RJ, Mastrangelo D, Maitra A, Tomlinson GE and Gazdar AF. (2003). Clin. Cancer Res., 9, 3674-3678.
24. Rathi A, Virmani AK, Schorge JO, Elias KJ, Maruyama R, Minna JD, Mok SC, Girard L, Fishman DA and Gazdar AF. (2002). Clin. Cancer Res., 8, 3324-3331.
25. Reynet C and Kahn CR. (1993). Science, 262, 1441-1444.
26. Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI and Carbone M. (2001). Semin. Cancer Biol., 11, 63-71.
27. Rood BR, Zhang H, Weitman DM and Cogen PH. (2002). Cancer Res., 62, 3794-3797.
28. Sandberg AA and Bridge JA. (2001). Cancer Genet. Cytogenet., 127, 93-110.
29. Sato F, Shibata D, Harpaz N, Xu Y, Yin J, Mori Y, Wang S, Olaru A, Deacu E, Selaru FM, Kimos MC, Hytiroglou P, Young J, Leggett B, Gazdar AF, Toyooka S, Abraham JM and Meltzer SJ. (2002). Cancer Res., 62, 6820-6822.
30. Shibata DM, Sato F, Mori Y, Perry K, Yin J, Wang S, Xu Y, Olaru A, Selaru F, Spring K, Young J, Abraham JM and Meltzer SJ. (2002). Cancer Res., 62, 5637-5640.
31. Shivapurkar N, Harada K, Reddy J, Scheuermann RH, Xu Y, McKenna RW, Milchgrub S, Kroft SH, Feng Z and Gazdar AF. (2002). Lancet, 359, 851-852.
32. Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, McKenna RW, Feng Z and Gazdar AF. (2004a). Cancer Res., 64, 3757-3760.
33. Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM and Gazdar AF. (2004b). Int. J. Cancer, 109, 786-792.
34. Shivapurkar N, Wiethege T, Wistuba II, Salomon E, Milchgrub S, Muller KM, Churg A, Pass H and Gazdar AF. (1999). J. Cell Biochem., 76, 181-188.
35. Slack A, Cervoni N, Pinard M and Szyf M. (1999). J. Biol. Chem., 274, 10105-10112.
36. Soejima K, Fang W and Rollins BJ. (2003). Oncogene, 22, 4723-4733.
37. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, Clausen PA, Calothy G and Blair DG. (1997). Mol. Cell. Biol., 17, 4801-4810.
38. Topol LZ, Modi WS, Koochekpour S and Blair DG. (2000). Cytogenet. Cell Genet., 89, 79-84.
39. Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD and Gazdar AF. (2002). Oncogene, 21, 4340-4344.
40. Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD and Gazdar AF. (2001). Cancer Res., 61, 5727-5730.
41. Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH and Kahn CR. (2001). Cancer Res., 61, 2071-2079.
42. van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG and Versteeg R. (2002). Cancer Res., 62, 2157-2161.
43. Virmani A, Rathi A, Heda S, Sugio K, Lewis C, Tonk V, Takahashi T, Roth JA, Minna JD, Euhus DM and Gazdar AF. (2003a). Int. J. Cancer, 107, 341-345.
44. Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD and Gazdar AF. (2003b). Int. J. Cancer, 106, 198-204.
45. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB. (1995). Nat. Med., 1, 570-577.
46. Wong L, Zhou J, Anderson D and Kratzke RA. (2002). Lung Cancer, 38, 131-136.
47. Yang B, Guo M, Herman JG and Clark DP. (2003). Am. J. Pathol., 163, 1101-1107.
48. Zanella CL, Posada J, Tritton TR and Mossman BT. (1996). Cancer Res., 56, 5334-5338.